These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12577776)

  • 1. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Janssen CA
    Ned Tijdschr Geneeskd; 2003 Jan; 147(3):135; author reply 135-6. PubMed ID: 12577776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Misleading advertising claims about the indication of doxazosin (Cardura) for type 2 diabetes mellitus and hypertension].
    Hoogenberg K; van der Tuin J
    Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2099-100. PubMed ID: 12448967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxazosin, an inferior antihypertensive agent?
    Furberg CD
    J Hum Hypertens; 2002 Jun; 16(6):375-7. PubMed ID: 12037690
    [No Abstract]   [Full Text] [Related]  

  • 4. [Doxazosin and heart failure: a clinical conclusion is wanted].
    Järhult B; Lindahl SO
    Lakartidningen; 2003 Dec; 100(51-52):4328. PubMed ID: 14756102
    [No Abstract]   [Full Text] [Related]  

  • 5. [Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?].
    Gustafsson LL
    Lakartidningen; 2004 Jan; 101(3):228-9. PubMed ID: 14763097
    [No Abstract]   [Full Text] [Related]  

  • 6. Doxazosin in the current treatment of hypertension.
    Wykretowicz A; Guzik P; Wysocki H
    Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxazosin for the management of hypertension: implications of the findings of the ALLHAT trial.
    Poulter N; Williams B
    Am J Hypertens; 2001 Nov; 14(11 Pt 1):1170-2. PubMed ID: 11724218
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alfadil--positive documentation when it comes to safety is missing].
    Furberg C
    Lakartidningen; 2003 Dec; 100(51-52):4329; discussion 4330. PubMed ID: 14756103
    [No Abstract]   [Full Text] [Related]  

  • 10. On call. I'm a 76-year-old man with an enlarged prostate. I've been taking Cardura and it's helped a lot, but my doctor stopped it because he said a study found the drug could cause heart failure. Now I'm getting up three or four times a night again. Is Cadura safe?
    Simon HB
    Harv Mens Health Watch; 2001 Jul; 5(12):8. PubMed ID: 11511462
    [No Abstract]   [Full Text] [Related]  

  • 11. Doxazosin gastrointestinal therapeutic system: a clinical perspective.
    Mann SJ
    J Clin Hypertens (Greenwich); 2006 Mar; 8(3):207-8. PubMed ID: 16522999
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antihypertensive therapy with doxazosin in patients with non-insulin-dependent diabetes mellitus].
    Lazebnik LB; Melichenko SB; Serebrov AN
    Ter Arkh; 1998; 70(2):50-4. PubMed ID: 9551574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J; Solar M
    Blood Press; 2009; 18(1-2):74-7. PubMed ID: 19353415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart lines. Cardura update.
    Harv Heart Lett; 2001 Sep; 12(1):5-6. PubMed ID: 11572810
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alpha blocker for protection against hypertensive target-organ damage].
    Ebina T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():578-82. PubMed ID: 15171439
    [No Abstract]   [Full Text] [Related]  

  • 16. [Use of doxazosin (Cardura-Pfizer), alpha 1-adrenoreceptor antagonist, in treatment of hypertension in patients with diabetes].
    Grzeszczak W
    Wiad Lek; 1998; 51 Suppl 2():5-10. PubMed ID: 9686527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!].
    Wepner U
    MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibility of predicting the use of doxazosin in the treatment of arterial hypertension].
    Khlynova OV; Tuev AV; Agafonov AV; Shkliaeva LN
    Klin Med (Mosk); 2003; 81(10):48-50. PubMed ID: 14664175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Doxazosin. A postsynaptic alpha 1-adrenergic receptor blocker in therapy of hypertension].
    Dominiak P
    Internist (Berl); 1993 Jul; 34(7):682-7. PubMed ID: 8103510
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of doxazosin gastrointestinal therapeutic system as third-line antihypertensive therapy on blood pressure and lipids in the Anglo-Scandinavian Cardiac Outcomes Trial.
    Chapman N; Chang CL; Dahlöf B; Sever PS; Wedel H; Poulter NR;
    Circulation; 2008 Jul; 118(1):42-8. PubMed ID: 18559700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.